Related Experiment Video
Updated: May 10, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Stratifying Multiple Sclerosis Susceptibility Risk: The Role of HLA-E*01 and Infectious Mononucleosis in a Population
Andrea Nova1, Davide Gentilini1,2, Giovanni Di Caprio1
1Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Background:
Epstein-Barr Virus (EBV) and its clinical manifestation, infectious mononucleosis (IM), are strongly linked to MS risk. A recent in vitro study suggests that HLA-E*01:03, in contrast to HLA-E*01:01, may protect against MS through more effective immune responses against EBV-infected B cells. However, the role of HLA-E*01 in MS remains unclear.
Methods:
We investigated if HLA-E*01:01 was significantly associated with higher MS risk in individuals with a history of IM diagnosis, using 487,144 individuals from the UK Biobank's cohort. We estimated the interaction between HLA-E*01:01 and IM using Cox proportional hazard models, adjusting for demographics, smoking, childhood body size, older siblings, and MS-related HLA alleles (e.g., HLA-DRB1*15:01).
Results:
HLA-E*01:01 allele alone was not significantly associated with IM or MS (p > 0.05). However, a significant interaction between HLA-E*01:01 and IM history was observed in relation to MS risk (p < 0.001). Specifically, MS risk was significantly higher in both HLA-E*01:01 heterozygotes (HR = 1.74 [95% CI: 1.36, 1.97], p < 0.001) and homozygotes (HR = 3.01 [95% CI: 1.81, 3.88], p < 0.001) with IM history, compared to HLA-E*01:03 homozygotes. Conversely, these associations were non-significant in individuals without IM history (p > 0.05). The estimated proportion of the combined risk attributable to interaction effects was 40% in HLA-E*01:01 heterozygotes and 65% in HLA-E*01:01 homozygotes.
Conclusions:
HLA-E*01:01 carriers diagnosed with IM are at significantly increased risk of MS, independently from other MS-related HLA alleles. This supports the hypothesis that HLA-E*01:01 may contribute to MS susceptibility due to weaker immune control over EBV infection. Incorporating HLA-E*01:01 into existing MHC-based MS risk models could then enhance personalized risk assessments in individuals with IM history.
Insights
Individuals with the HLA-E*01:01 gene variant and a history of infectious mononucleosis (IM) face a significantly higher risk of developing multiple sclerosis (MS). This finding highlights a potential genetic link between EBV infection and MS susceptibility.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Infectious Disease Epidemiology
Background:
- Epstein-Barr Virus (EBV) infection and infectious mononucleosis (IM) are established risk factors for multiple sclerosis (MS).
- The human leukocyte antigen (HLA) system plays a critical role in immune responses and MS susceptibility.
- Previous in vitro studies suggested a protective role for HLA-E*01:03 against MS, contrasting with potential risks associated with HLA-E*01:01.
Purpose of the Study:
- To investigate the association between the HLA-E*01:01 allele and MS risk in individuals with a history of IM.
- To determine if HLA-E*01:01 interacts with IM history to modify MS risk.
- To evaluate the role of HLA-E*01 alleles in the context of EBV infection and MS pathogenesis.
Main Methods:
- Utilized a large cohort of 487,144 individuals from the UK Biobank.
- Employed Cox proportional hazard models to assess the interaction between HLA-E*01:01 and IM history.
- Adjusted for key covariates including demographics, smoking, body size, number of older siblings, and known MS-related HLA alleles like HLA-DRB1*15:01.
Main Results:
- The HLA-E*01:01 allele alone was not significantly associated with IM or MS.
- A significant interaction (p < 0.001) was found between HLA-E*01:01 and IM history regarding MS risk.
- MS risk was substantially elevated in HLA-E*01:01 heterozygotes (HR=1.74) and homozygotes (HR=3.01) with a history of IM, compared to HLA-E*01:03 homozygotes.
Conclusions:
- HLA-E*01:01 carriers with a history of IM exhibit significantly increased MS risk, independent of other HLA alleles.
- This finding supports the hypothesis that HLA-E*01:01 may impair immune control over EBV infection, contributing to MS susceptibility.
- Integrating HLA-E*01:01 status into risk models could improve personalized MS risk assessment for individuals with a history of IM.
More Related Videos
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Multiple Sclerosis l: Introduction